NT-501 ECT implant for Glaucoma
This trial is testing a new eye surgery for people with glaucoma. The surgery will either be the new treatment or a fake surgery, and no one will know which they got. There will be follow-up appointments to check safety and to see if the new treatment works better than the fake surgery.
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Is access to this research still available for volunteers?
"As per clinicaltrials.gov, this investigation is not currently recruiting individuals into its study cohort. It was initially posted in June 2016 and most recently updated on November 15th 2022; although it is presently inactive, there are 206 other trials that require participants at the time of writing."
Has the NT-501 ECT implant been certified by the FDA?
"Our team at Power judges the NT-501 ECT implant to be a 2 on the safety scale because of its Phase 2 nature; meaning there is some proof of security but none that it works."